MedPath

Dyslipidemia and Diabetic Retinopathy

Completed
Conditions
Dyslipidemia
Diabetic Retinopathy
Interventions
Other: 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
Other: Healthy Controls 15 age matched control subjects
Registration Number
NCT03403283
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.

Detailed Description

The purpose of this study is to determine if the reparative cells of blood vessels, called endothelial progenitor cells (EPC's) are defective in people with diabetes. Diabetic retinopathy (DR) is an eye disease related to diabetes. It can cause blurred vision and possible bleeding in the blood vessels in the back of the eye (retina). Damage to the cells of the blood vessels from DR can cause vision loss or blindness. Even with current treatments, the quality of life for people with DR is much reduced.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Any man or woman
  • Greater than 18 years of age
  • Diagnosis of diabetes (applies to the Diabetic Arm only) (N=15 Type 1 and N=15 Type
  • The subject must be willing and have the ability to cooperate with the protocol. Children will not be eligible because the investigators need to obtain 150 ml of blood and this is in excess of what can be drawn in children.
Read More
Exclusion Criteria
  • Female participants must not be pregnant at the time of the blood draw as evident through a dipstick pregnancy test.
  • Have retinal abnormalities other than diabetic retinopathy.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Diabetic15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic RetinopathyDiabetics with mild, moderate or severe non proliferative retinopathy and proliferative retinopathy
ControlsHealthy Controls 15 age matched control subjectsHealthy Controls
Primary Outcome Measures
NameTimeMethod
Increase in Acid Sphingomyelinase (ASM) Expression and Activity in Bone Marrow-derived Endothelial Progenitor Cells (EPCs)3 years

Peripheral blood of 150 cc, about 8-10 tablespoons will be collected from vein in the arm of both diabetic and control subjects.ASM activity was measured on a scale of 0-0.6. 0.6 is worse with units being nM/hr

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath